BNP PARIBAS FINANCIAL MARKETS - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2020. The put-call ratio across all filers is 4.17 and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$8,822,700
+293.1%
80,839
+127.6%
0.01%
+300.0%
Q2 2023$2,244,358
-26.9%
35,512
-48.0%
0.00%
-25.0%
Q1 2023$3,071,377
+4.8%
68,268
+2.1%
0.00%
-20.0%
Q4 2022$2,930,670
-99.9%
66,895
-1.5%
0.01%
-28.6%
Q3 2022$4,475,842,000
+198.7%
67,929
+129.0%
0.01%
+250.0%
Q2 2022$1,498,531,000
+177.0%
29,668
+250.4%
0.00%
+100.0%
Q1 2022$540,936,000
-59.1%
8,468
-31.5%
0.00%
-50.0%
Q4 2021$1,323,987,000
+22.5%
12,361
+17.6%
0.00%0.0%
Q3 2021$1,081,047,000
+99.2%
10,515
+70.4%
0.00%
+100.0%
Q2 2021$542,713,000
-71.4%
6,170
-19.1%
0.00%
-66.7%
Q1 2021$1,896,568,000
-26.4%
7,626
-66.8%
0.00%
-40.0%
Q4 2020$2,575,861,000
+115.4%
22,968
+78.1%
0.01%
+150.0%
Q3 2020$1,195,645,000
-65.7%
12,898
-71.2%
0.00%
-66.7%
Q2 2020$3,490,188,000
-8.5%
44,746
-31.4%
0.01%
-25.0%
Q1 2020$3,813,715,000
-44.5%
65,214
-23.9%
0.01%
-38.5%
Q4 2019$6,868,391,000
+940.6%
85,737
+854.3%
0.01%
+1200.0%
Q3 2019$660,054,000
+13.7%
8,984
+45.9%
0.00%0.0%
Q2 2019$580,695,000
-24.3%
6,156
-35.8%
0.00%
-50.0%
Q1 2019$767,519,000
+727.7%
9,588
+457.4%
0.00%
Q4 2018$92,725,000
-72.0%
1,720
-59.4%
0.00%
Q3 2018$330,974,000
+29.2%
4,240
+5.0%
0.00%
Q2 2018$256,269,000
-68.5%
4,037
-54.5%
0.00%
-100.0%
Q1 2018$813,562,000
+23.1%
8,872
+1.3%
0.00%
+100.0%
Q4 2017$660,667,000
+129.5%
8,761
+112.0%
0.00%0.0%
Q3 2017$287,876,000
+34.1%
4,132
-2.5%
0.00%0.0%
Q2 2017$214,739,000
+5674.1%
4,238
+4457.0%
0.00%
Q1 2017$3,719,000
-88.3%
93
-91.8%
0.00%
Q4 2016$31,893,000
-23.9%
1,137
-19.5%
0.00%
Q3 2016$41,936,000
+164.1%
1,412
+80.1%
0.00%
Q2 2016$15,876,000
-68.5%
784
-59.1%
0.00%
Q4 2015$50,468,000
-2.8%
1,916
-21.3%
0.00%
Q3 2015$51,942,0002,4340.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
View complete list of BLUEPRINT MEDICINES CORP shareholders